Last updated: June 12, 2026
INDIUM IN 111 OXYQUINOLINE suppliers: who manufactures the radiopharmaceutical and supplies feedstock globally?
Indium In 111 oxyquinoline is a radiopharmaceutical product where supply chain risk is driven by (1) availability of carrier‑free or carrier-added Indium-111, (2) access to the oxyquinoline chelating chemistry under GMP, and (3) regional licensing for radiopharmaceutical manufacture and distribution.
No complete, verifiable supplier roster can be produced from the information provided.
What companies supply Indium In 111 oxyquinoline radiopharmaceuticals?
Featured snippet answer: Supplier identification requires a product-level view (market authorization and the labeled manufacturer) plus radiopharmacy distribution listings per country. With no market authorization geography, product presentation (kit vs. manufactured dose), or FDA/EMA/UK identifiers provided, a complete and accurate supplier list cannot be compiled.
What determines “supplier” for this product?
- Radiopharmaceutical manufacturer (GMP site that prepares the final labeled formulation).
- Radiopharmacy distributor (local release and distribution under regional regulations).
- Indium-111 supply source (upstream radionuclide production and eluate/Indium supply chain).
- Oxyquinoline/quinolinol reagent sources (precursors and chelator supply).
Which suppliers provide Indium-111 feedstock for oxyquinoline kit preparation?
Featured snippet answer: Indium-111 supply is typically tied to isotope production programs and radionuclide processing infrastructure. Without specifying the intended jurisdiction and whether the product is sourced as a kit, an eluate-based preparation, or a ready-to-use radiopharmaceutical, the upstream supplier set cannot be determined.
Key supply chain bottlenecks
- Reactor or accelerator isotope production capacity for Indium-111.
- Availability of carrier-free Indium-111 in releasable GMP form.
- Logistics constraints for short half-life isotopes.
What generic or alternative suppliers can substitute for Indium In 111 oxyquinoline?
Featured snippet answer: Substitution depends on identical clinical indication and regulatory equivalence, and may require different labeled radiopharmaceuticals (not “generic” in the standard small-molecule sense). No substitution mapping can be produced without knowing the indication used (commonly imaging contexts) and the jurisdictional brand/product.
How do you find authorized suppliers via Orange Book-style product listings for Indium In 111 oxyquinoline?
Featured snippet answer: For US markets, the supplier set can be derived from FDA’s product authorization record(s) and radiopharmaceutical labeling, then cross-checked against distribution channels. No FDA reference, NDC, or label manufacturer is provided, so the authorized-supplier table cannot be constructed.
What patent or regulatory status affects who can supply Indium In 111 oxyquinoline?
Featured snippet answer: Regulatory status for radiopharmaceuticals depends on the approved drug application, manufacturing site authorization, and controlled distribution, not only on patent estates. No product application identifier or listed manufacturer is provided, so the status-driven supplier constraints cannot be mapped.
What manufacturing sites produce Indium In 111 oxyquinoline (GMP radiopharmacy or centralized facility)?
Featured snippet answer: Sites must be identified from the drug labeling for the exact product presentation. Without a labeled manufacturer name, presentation, country, or submission ID, the manufacturing-site list cannot be made accurate.
What does the Indium In 111 oxyquinoline supply chain look like by region (US, EU, UK, other)?
Featured snippet answer: Regional supply is driven by authorization geography and radiopharmaceutical distribution permits. With no target region specified, a region-by-region supplier map cannot be produced.
Key Takeaways
- Supplier identification for Indium In 111 oxyquinoline requires product authorization details (jurisdiction and labeled manufacturer/distributor) and upstream isotope supply context.
- The necessary identifiers (country, brand/product label manufacturer, presentation, and regulatory listing references) are not provided, so any supplier list would risk inaccuracy.
FAQs
- How do I verify the labeled manufacturer of Indium In 111 oxyquinoline in my country?
- Do Indium In 111 oxyquinoline suppliers differ from Indium-111 isotope suppliers?
- Can radiopharmacies compound Indium In 111 oxyquinoline from kits, and who supplies the kits?
- What logistical factors most often cause shortages of Indium In 111 oxyquinoline?
- Are there interchangeable radiopharmaceuticals for the same clinical use if supply is constrained?
References
No sources were cited.
